BIOCHIPS - An Exclusive Market Insight Report Update

Fundamentally, biochips are computer-chip look-alikes intended to speedily, reliably, and inexpensively perform biochemical procedures that together constitute a medical test.

Hyderabad, India (prHWY.com) May 8, 2012 - April 18, 2012- RI Technologies' ( http://www.researchimpact.com/ ) report on Biochips studies the impact of Biochips in various applications. The study focuses on major Biochip Types, Applications and Biochips Related Products. The emphasis is also given on major Biochips Types including DNA, Protein, Lab-On-Chip and Other (Cellular chips, Tissue chips, Drug of Abuse Chips , etc.) in various Applications such as Drug Discovery& Development, Genomics, and Clinical Diagnosis and Other (Water and Environmental Testing, Forensics, Identity Testing, etc.). Biochip Related Products including Instruments, Software, Reagents and Consumables, and Services are also discussed in detail. The study includes estimations and predictions for the total global Biochips market. Market is also analyzed by geographic regions encompassing North America, Europe, Japan, Asia-Pacific and Rest of World. Business profiles of 35 major companies are discussed in the report. The report serves as a guide to global Biochips industry covering more than 400 companies engaged in Biochips research, development and supply of products and services. Major Contract Research Organizations and Universities serving the global Biochips industry are also covered in the Corporate Directory section of this report. Compilation of Worldwide Patents and Research related to Biochips is also provided. Information related product developments, partnerships, collaborations, and mergers and acquisitions are also covered in the report featuring 200 graphically represented exclusive exhibits.


Global Biochips market is projected to grow at 21% compounded annually from 2005 through 2015. This growth would be driven especially by application of biochips in clinical diagnosis, Drug Development. Biochips are expected to increase the number of drugs released by reducing the time involved in the drug development process, leading to savings in time and costs. Biochips are becoming an essential part of drug discovery process, bolstering efficiency and accuracy.

A biochip is a combination of micro fabrication technology and life sciences in a miniaturized device. Small enough to fit the palm of the hand the so-called "lab on a chip" or micro total analysis systems (µTAS) employs miniaturization of biological separation and assay techniques to an extent that multiple and complex analyses can be done on a chip. Fundamentally, biochips are computer-chip look-alikes intended to speedily, reliably, and inexpensively perform biochemical procedures that together constitute a medical test. The far slower, more cumbersome, more expensive laboratory equipment can be replaced by their miniaturization and automation of laboratory procedures. Their current applications lie principally in the analysis of genes for defects or sequence variations. They may soon facilitate screening of molecules for potential usefulness as drugs. The immediate goal is to enable them to serve point-of-care diagnosis.

Biochips have become an integral part in the process of drug discovery since the last few years. Biochips market in the global arena is on an upward swing. Biochips which save time in target identification and consequently reduce R & D costs significantly are a boon to drug manufacturing industries. New drug research uses biochips for drug assays and also to test them for toxicity. This is done so that fewer, or perhaps eventually, no animal testing needs to be done. The concept of personalized medicine is also driving the growth of the demand for biochip. A positive regulatory swing towards use of biochips is anticipated, which may decrease the drug's time to market and eventually increase monetary inflows. Biochips are playing a key role in clinical diagnosis i.e. they help in diagnosis of disease even before the symptoms are observed Biochips which can identify the presence of different proteins, Nucleic acids, different bacteria etc. in a single analysis help to diagnose the disease.

About RI Technologies

RI Technologies is a premier source of market research on the Biotechnology & Healthcare sector with exclusive focus on product segments, global and regional market analysis, technology trends, industry outlook, competitor profiles, corporate directory and patents information. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The dedicated team works 24/7 to deliver unique reports that are of immense value to investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools. The company's reports provide strategic information tools to the manufacturers, retailers, distributors, and suppliers that will help them to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. The strategic market information tables, graphically represented, will aid companies' research needs and help in forecasting, and gearing up to the future. Emphasis is on factual insights and forecasts with maximum global coverage. The company strives to provide market insight reports that empower customers with enlightening critical business information.

###

Tag Words: biochips

Categories: Biotech

Press Release Contact
Customer Support: contactus@researchimpact.com. Call us at INDIA: +91 9676994272 / UK: 076-24-057837 for your biotechnology and healthcare market research report requirements. We provide 24/7 online.

Link To This Press Release:

URL HTML Code